HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Different protection mechanisms after pretreatment with glycine or alpha-lipoic acid in a rat model of warm hepatic ischemia.

AbstractBACKGROUND/AIM:
Alpha-lipoic (LA) acid pretreatment has previously been described to reduce ischemia/reperfusion injury (IRI) after warm liver ischemia, whereas glycine pretreatment has been shown to be protective mostly in models of cold hepatic ischemia. The aim of this study was to determine whether glycine decreases IRI after warm hepatic ischemia. Furthermore we investigated whether doses of LA other than those used previously are also protective against IRI after warm hepatic ischemia.
METHODS:
Selective liver ischemia was maintained over a period of 90 min. In long-term as well as short-term experiments we studied IRI in several groups comparing animal survival as the pivotal endpoint.
RESULTS:
Animal survival was improved by glycine and 5,000 micromol LA, whereas all animals died within 3 days after pretreatment with 50 micromol LA. In the glycine group we observed a tendency towards decreased apoptosis-related cell death measured by the activity of caspase-3 in liver tissue and the percentage of TUNEL-positive hepatocytes in comparison to the untreated group. Serum alpha-glutathione S-transferase, lipid peroxidation, and caspase-3 activity as well as the percentage of TUNEL-positive hepatocytes and the percentage of liver necrosis were only significantly decreased by 5,000 micromol LA pretreatment. Liver tissue levels of tumor necrosis factor (TNF)alpha were reduced only in the glycine group whereas TNFalpha was increased in the untreated as well as the LA group. Levels of TNFalpha mRNA were upregulated in both the glycine- and LA-pretreated groups.
CONCLUSION:
Our data show that increased animal survival by glycine was accompanied by a reduced TNFalpha content in liver tissue. Protection by glycine is likely to result from a reduction in adverse TNFalpha effects. Administration of high-dose LA on the other hand led to a significant reduction in necrosis- and apoptosis-related cell death in IRI of the liver without a reduction in liver TNFalpha.
AuthorsFriedrich Duenschede, Stefanie Westermann, Nina Riegler, Imke Miesner, Kirsten Erbes, Patrick Ewald, Achim Kircher, Hella Schaefer, Julius Schneider, Arno Schad, P Dutkowski, A K Kiemer, Theodor Junginger
JournalEuropean surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes (Eur Surg Res) Vol. 38 Issue 6 Pg. 503-12 ( 2006) ISSN: 0014-312X [Print] Switzerland
PMID17028433 (Publication Type: Journal Article)
CopyrightCopyright 2006 S. Karger AG, Basel.
Chemical References
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Thioctic Acid
  • L-Lactate Dehydrogenase
  • Lipoxygenase
  • Glutathione Transferase
  • Glycine
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cytoprotection
  • Glutathione Transferase (metabolism)
  • Glycine (therapeutic use)
  • In Situ Nick-End Labeling
  • L-Lactate Dehydrogenase (metabolism)
  • Lipoxygenase (analysis)
  • Liver (blood supply, enzymology)
  • Male
  • RNA, Messenger (analysis)
  • Rats
  • Reperfusion Injury (prevention & control)
  • Thioctic Acid (therapeutic use)
  • Tumor Necrosis Factor-alpha (analysis, genetics)
  • Warm Ischemia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: